ART-2 Pilot - Driving Pressure Limited Ventilation for Patients With ARDS
ART2pilot
ART-2 Pilot: A Controlled, Randomized Trial to Assess the Feasiblity of a Driving Pressure Limited Ventilation vs. Standard Strategy (ARDSNet) in Patients With ARDS
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
This is a multicenter randomized controlled pilot trial to investigate the feasibility of a driving pressure limited mechanical ventilation strategy compared to the ARDS Clinical Network strategy (conventional strategy) in patients with acute respiratory distress syndrome (ARDS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jun 2015
Typical duration for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2015
CompletedFirst Posted
Study publicly available on registry
February 18, 2015
CompletedStudy Start
First participant enrolled
June 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedJuly 28, 2021
February 1, 2015
1.7 years
February 6, 2015
July 21, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Mean driving pressure between day 1 and day 3
Driving pressure is the difference between plateau pressure and PEEP. It will be measured every morning in patients without spontaneous efforts. As every patients will have up to three measurements, we will consider the mean driving pressure for each patient.
Day 1 to Day 3 after randomization
Secondary Outcomes (17)
Adherence to study procedures: daily adjustement of driving pressure in experimental group and tidal volume in the control group
Days 1 to 7
Rate of driving pressure equal or lower than 13cmH2O
Days 1 to 3 after randomization
Mean PEEP from day 1 to 7
Days 1 to 7
Mean tidal volume from day 1 to day 7
Days 1 to 7
Mean static compliance of the respiratory system from day 1 to day 7
Days 1 to 7
- +12 more secondary outcomes
Study Arms (2)
Driving pressure limited ventilation
EXPERIMENTALDriving pressure limited ventilation
Conventional ventilation
ACTIVE COMPARATORMechanical ventilation as proposed in the ARDSNet protocol.
Interventions
We will use volume controlled ventilation or pressure support in the weaning phase. We will adjust tidal volume between 3 and 8 mL/Kg of predicted body weight in order to achieve a driving pressure of 13 cmH2O. The respiratory rate will be titrated to achieve a pH between 7.30 and 7.45 (maximum respiratory rate is 50 breathings per minute). We will not limit plateau pressure in this arm.
ARDSNet Strategy: conventional mechanical ventilation strategy with tidal volume between 4 and 6 mL/kg of predicted body weight and plateau pressure limited to 30 cmH2O.
Eligibility Criteria
You may qualify if:
- Patients on invasive mechanical ventilation with diagnosis of ARDS of less than 72 hours duration.
You may not qualify if:
- Less than 18 years old.
- Presence of any contraindication to hypercapnia as suspected or confirmed intracranial hypertension or recent (\<7 days) acute coronary syndrome.
- Patients in which a high probability of death within 24 hours is anticipated.
- Patients under exclusive palliative care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Pereira Romano ML, Maia IS, Laranjeira LN, Damiani LP, Paisani DM, Borges MC, Dantas BG, Caser EB, Victorino JA, Filho WO, Amato MBP, Cavalcanti AB. Driving Pressure-limited Strategy for Patients with Acute Respiratory Distress Syndrome. A Pilot Randomized Clinical Trial. Ann Am Thorac Soc. 2020 May;17(5):596-604. doi: 10.1513/AnnalsATS.201907-506OC.
PMID: 32069068DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alexandre B Cavalcanti, MD, PhD
Hospital do Coracao (Heart Hospital)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2015
First Posted
February 18, 2015
Study Start
June 12, 2015
Primary Completion
February 25, 2017
Study Completion
July 1, 2017
Last Updated
July 28, 2021
Record last verified: 2015-02